Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,011) Arrow Down
Filter Results: (1,011) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,011)
    • People  (3)
    • News  (261)
    • Research  (630)
    • Events  (1)
    • Multimedia  (6)
  • Faculty Publications  (297)

Show Results For

  • All HBS Web  (1,011)
    • People  (3)
    • News  (261)
    • Research  (630)
    • Events  (1)
    • Multimedia  (6)
  • Faculty Publications  (297)
← Page 19 of 1,011 Results →
  • September 2010 (Revised November 2011)
  • Case

Salud Digna: Successfully Competing with For-Profit Organizations

By: Allen S. Grossman and Regina Garcia-Cuellar
Hugo Moreno, CEO of Salud Digna, was considering his growth options for the next three years. Would becoming a for-profit with access to greater capital be the best strategy or would this cause the organization to lose its social mission? Salud Digna provided... View Details
Keywords: For-Profit Firms; Health Testing and Trials; Growth and Development Strategy; Corporate Social Responsibility and Impact; Mission and Purpose; Nonprofit Organizations; Health Industry; Mexico
Citation
Educators
Purchase
Related
Grossman, Allen S., and Regina Garcia-Cuellar. "Salud Digna: Successfully Competing with For-Profit Organizations." Harvard Business School Case 311-051, September 2010. (Revised November 2011.)

    Satish K. Tadikonda

    Satish Tadikonda is a Senior Lecturer in the Entrepreneurial Management Unit at Harvard Business School. In the MBA program, Satish teaches The Entrepreneurial Manager, a required first-year MBA course, and Entrepreneurship in Life Sciences, an elective course for... View Details

    • 09 Mar 2018
    • News

    Master Protocols in Oncology: A Review of the Landscape

      Rational Habit Formation

      Regular handwashing with soap is believed to have substantial impacts on child health in the developing world. Most handwashing campaigns have failed, however, to establish and maintain a regular practice of handwashing. Motivated by scholarship that suggests... View Details

      • April 2004 (Revised May 2007)
      • Case

      Conor Medsystems

      By: Donald N. Sull, Robert F. Higgins, Linda A. Cyr and Bijan Salehizadeh
      Conor Medsystems had developed a drug-eluting stent that could capture significant share of the $5 billion global market. Chief executive officer, Frank Litvack, is considering alternative sources of financing to test the device. View Details
      Keywords: Entrepreneurship; Health Testing and Trials; Corporate Finance; Medical Devices and Supplies Industry
      Citation
      Educators
      Purchase
      Related
      Sull, Donald N., Robert F. Higgins, Linda A. Cyr, and Bijan Salehizadeh. "Conor Medsystems." Harvard Business School Case 804-180, April 2004. (Revised May 2007.)
      • March–April 2017
      • Article

      What's the Value of a Like?: Social Media Endorsements Don't Work the Way You Might Think

      By: Leslie John, Daniel Mochon, Oliver Emrich and Janet Schwartz
      Brands spend billions of dollars a year on lavish efforts to establish and maintain a social media presence. But do those campaigns actually increase revenue? New research provides an answer to this question, which has vexed marketers ever since social media burst upon... View Details
      Keywords: Social and Collaborative Networks; Consumer Behavior; Marketing Strategy; Digital Marketing; Social Media
      Citation
      Find at Harvard
      Register to Read
      Related
      John, Leslie, Daniel Mochon, Oliver Emrich, and Janet Schwartz. "What's the Value of a Like? Social Media Endorsements Don't Work the Way You Might Think." Harvard Business Review 95, no. 2 (March–April 2017): 108–115.
      • August 1995 (Revised June 1997)
      • Case

      Hillcrest Research Associates, Inc.

      Hillcrest designs and administers testing procedures for drugs to determine whether they pass FDA specifications. As the company grows, it encounters problems with information technology and with the clinical research associates, who feel pressured to report more... View Details
      Keywords: Growth Management; Information Technology; Health Testing and Trials; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Barnes, Louis B. "Hillcrest Research Associates, Inc." Harvard Business School Case 496-021, August 1995. (Revised June 1997.)
      • February 2019 (Revised July 2025)
      • Case

      Theranos: Who Has Blood on Their Hands? (A)

      By: Nien-hê Hsieh, Christina R. Wing, Emilie Fournier and Anna Resman
      This case covers the rise and fall of Theranos, the company founded by Elizabeth Holmes in 2004 to revolutionize the blood testing industry by creating a device that could provide from a small finger prick the same results and accuracy as intravenous blood draws. As... View Details
      Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Ethics; Entrepreneurship; Lawsuits and Litigation
      Citation
      Educators
      Purchase
      Related
      Hsieh, Nien-hê, Christina R. Wing, Emilie Fournier, and Anna Resman. "Theranos: Who Has Blood on Their Hands? (A)." Harvard Business School Case 619-039, February 2019. (Revised July 2025.)
      • January 2011 (Revised March 2011)
      • Case

      Predictive Biosciences

      By: Thomas R. Eisenmann, Jeffrey J. Bussgang and David Kiron
      A small cancer diagnostics start-up is deciding whether to acquire a laboratory to make and sell its bladder cancer test or build its own manufacturing and sales team. View Details
      Keywords: Mergers and Acquisitions; Factories, Labs, and Plants; Business Startups; Entrepreneurship; Health Testing and Trials; Growth and Development Strategy; Product Development; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Eisenmann, Thomas R., Jeffrey J. Bussgang, and David Kiron. "Predictive Biosciences." Harvard Business School Case 811-015, January 2011. (Revised March 2011.)
      • 14 Jul 2006
      • Op-Ed

      The Case for Consumer-Driven Medicaid

      The Medicaid program provides a much needed health insurance safety net for 52 million of our nation's poor and medically needy, but its price tag threatens the financial stability of the states, growing 9.5... View Details
      Keywords: by Regina E. Herzlinger
      • Research Summary

      Overview

      The Information Age has introduced well-received opportunities to track performance. Fitbits and Fuelbands allow individuals to track their own performance; companies like Uber and leading hospitals help you choose a driver or a doctor based on how others rated... View Details

      Keywords: Management Accounting; Disclosure; Performance Measurement; Incentives; Control; Education; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States; Japan; India

        Meeting the Challenge of Corporate Entrepreneurship

        To be competitive, companies must grow innovative new businesses. Corporate entrepreneurship, however, isn't easy. New ventures face innumerable barriers and seldom mesh smoothly with well-established systems, processes, and cultures. Nonetheless, success requires a... View Details

        • September 2020
        • Case

        Minerva 2004: Discovery

        By: John R. Wells and Benjamin Weinstock
        After nearly five years in operation, Doctor Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), was reflecting on the company’s next steps. In a few short years, she and her small team had managed to develop a nanoparticle process for... View Details
        Keywords: Entrepreneurship; Financing and Loans; Strategy; Decision Choices and Conditions; Biotechnology Industry
        Citation
        Educators
        Purchase
        Related
        Wells, John R., and Benjamin Weinstock. "Minerva 2004: Discovery." Harvard Business School Case 721-389, September 2020.
        • 2013
        • Working Paper

        Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time

        By: Jillian Berry Jaeker, Anita L. Tucker and Michael H. Lee
        We exploit an exogenous process change at two emergency departments (EDs) within a health system to test the theory that increasing capacity in a discretionary work setting increases wait times due to additional services being provided to customers as a consequence of... View Details
        Keywords: Technology; Demand and Consumers; Service Delivery; Health Care and Treatment; Business Processes; Health Industry
        Citation
        Read Now
        Related
        Berry Jaeker, Jillian, Anita L. Tucker, and Michael H. Lee. "Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time." Harvard Business School Working Paper, No. 14-033, October 2013.
        • July–September 2018
        • Article

        Memory Bias in Observer-Performance Literature

        By: Tamara M. Haygood, Samantha N. Smith and Jia Sun
        The objective of our study was to determine how authors of published observer–performance experiments dealt with memory bias in study design. We searched American Journal of Roentgenology online and Radiology using “observer study” and “observer performance.” We... View Details
        Keywords: Health Care and Treatment; Research
        Citation
        Read Now
        Related
        Haygood, Tamara M., Samantha N. Smith, and Jia Sun. "Memory Bias in Observer-Performance Literature." Art. 031412. Journal of Medical Imaging 5, no. 3 (July–September 2018).

          The Power of Experiments

          Have you logged into Facebook recently? Searched for something on Google? Chosen a movie on Netflix? If so, you've probably been an unwitting participant in a variety of experiments—also known as randomized controlled trials—designed to test the impact of... View Details

          • 01 Dec 2003
          • Research & Ideas

          Sometimes Success Begins at Failure

          In the late 1980s, scientists for New York City-based drug-maker Pfizer began testing what was then known as compound UK-92,480 for the treatment of angina. Although UK-92,480 seemed promising in the lab and... View Details
          Keywords: by Henry Chesbrough; Health; Health
          • 2025
          • Working Paper

          How Firms Respond to Worker Activism: Evidence from Global Supply Chains

          By: Yanhua Bird, Jodi L. Short and Michael W. Toffel
          Social movement pressures can lead organizations to concede and improve social performance to avoid disruption costs, but we theorize that such responses evoke concession costs that prompt organizations to shift resources and attention from other social domains whose... View Details
          Keywords: Worker Activism; Labor Standards; Tradeoffs; Global Supply Chains; Internal Governance Structure; Public Opinion; Supply Chain; Corporate Accountability; Corporate Social Responsibility and Impact; Working Conditions
          Citation
          SSRN
          Read Now
          Related
          Bird, Yanhua, Jodi L. Short, and Michael W. Toffel. "How Firms Respond to Worker Activism: Evidence from Global Supply Chains." Harvard Business School Working Paper, No. 25-061, June 2025.
          • April 2003 (Revised October 2004)
          • Case

          Novartis: The Challenge of Success (A)

          By: Sandra J. Sucher and Stacy McManus
          Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the... View Details
          Keywords: Decision Making; Health Testing and Trials; Innovation and Invention; Markets; Distribution; Product Development; Production; Problems and Challenges; Research; Research and Development; Complexity; Biotechnology Industry; Pharmaceutical Industry
          Citation
          Educators
          Purchase
          Related
          Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
          • June 2023
          • Case

          Verve Therapeutics: Taking DNA Editing to Heart

          By: Shikhar Ghosh and Shweta Bagai
          Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
          Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
          Citation
          Educators
          Purchase
          Related
          Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
          • ←
          • 19
          • 20
          • …
          • 50
          • 51
          • →
          ǁ
          Campus Map
          Harvard Business School
          Soldiers Field
          Boston, MA 02163
          →Map & Directions
          →More Contact Information
          • Make a Gift
          • Site Map
          • Jobs
          • Harvard University
          • Trademarks
          • Policies
          • Accessibility
          • Digital Accessibility
          Copyright © President & Fellows of Harvard College.